Henderson Jane
Chief Financial Officer · 18 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | APGE | Apogee Therapeutics, Inc. | Sale | 900 | $82.60 | $74,340.00 | filing |
| 2026-05-01 | APGE | Apogee Therapeutics, Inc. | Sale | 811 | $81.02 | $65,707.22 | filing |
| 2026-05-01 | APGE | Apogee Therapeutics, Inc. | Sale | 289 | $83.16 | $24,033.24 | filing |
| 2026-04-16 | APGE | Apogee Therapeutics, Inc. | Sale | 2,000 | $90.00 | $180,000.00 | filing |
| 2026-04-01 | APGE | Apogee Therapeutics, Inc. | Sale | 1,100 | $85.46 | $94,006.00 | filing |
| 2026-04-01 | APGE | Apogee Therapeutics, Inc. | Sale | 900 | $84.46 | $76,014.00 | filing |
| 2026-03-25 | APGE | Apogee Therapeutics, Inc. | Sale | 2,000 | $85.00 | $170,000.00 | filing |
| 2026-02-02 | APGE | Apogee Therapeutics, Inc. | Sale | 1,108 | $66.15 | $73,294.20 | filing |
| 2026-02-02 | APGE | Apogee Therapeutics, Inc. | Sale | 792 | $65.21 | $51,646.32 | filing |
| 2026-02-02 | APGE | Apogee Therapeutics, Inc. | Sale | 100 | $66.89 | $6,689.00 | filing |
| 2026-01-06 | APGE | Apogee Therapeutics, Inc. | Sale | 2,000 | $80.00 | $160,000.00 | filing |
| 2026-01-02 | APGE | Apogee Therapeutics, Inc. | Sale | 4,080 | $75.20 | $306,816.00 | filing |
| 2026-01-02 | APGE | Apogee Therapeutics, Inc. | Sale | 1,920 | $74.13 | $142,329.60 | filing |
| 2025-12-19 | APGE | Apogee Therapeutics, Inc. | Sale | 1,500 | $80.00 | $120,000.00 | filing |
| 2025-12-04 | APGE | Apogee Therapeutics, Inc. | Sale | 1,500 | $75.00 | $112,500.00 | filing |
| 2025-11-25 | APGE | Apogee Therapeutics, Inc. | Sale | 1,500 | $70.00 | $105,000.00 | filing |
| 2025-11-14 | APGE | Apogee Therapeutics, Inc. | Sale | 2,000 | $65.00 | $130,000.00 | filing |
| 2025-11-11 | APGE | Apogee Therapeutics, Inc. | Sale | 1,000 | $60.00 | $60,000.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.